by Symmetron | Jan 21, 2019
Hypertension Clinical effectiveness analysis of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension: a systematic review of randomized controlled trials Agency for Health Technology Assessment in Poland,...
by Symmetron | Jan 21, 2019
Hypertension Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation Health Technology Assessment....
Recent Comments